A De-Novo drug design and ADMET study to design small molecule stabilisers targeting mutant (V210I) human prion protein against familial Creutzfeldt-Jakob disease (fCJD)

Rafat Alam, G. M. Sayedur Rahman, Nahid Hasan, Abu Sayeed Chowdhury. A De-Novo drug design and ADMET study to design small molecule stabilisers targeting mutant (V210I) human prion protein against familial Creutzfeldt-Jakob disease (fCJD). I. J. Computational Biology and Drug Design, 13(1):21-35, 2020. [doi]

Abstract

Abstract is missing.